NextBio, a medical solutions provider, announced the launch of NextBio Clinical, an extension of the company’s existing life science platform, which translates medicine applications such as biomarker discovery and clinical trial optimization. Adding curated genomic, molecular and clinical profiles from thousands of individual patients to the platform’s existing repository of data from animal and cell line models, NextBio Clinical enables the earlier application of clinical information to enhance research and development.
Since 2004, NextBio has been addressing the research needs of scientists at academic institutions, pharmaceutical and biotech companies with our cross-technology platform for integrative data analysis, Now, with NextBio Clinical, addresses the challenges of taking genomics into clinical research for the development of therapeutics and companion diagnostics. By providing patient-centric data and analysis, NextBio facilitates biomarker-driven research that can accelerate the process of translational drug discovery.
NextBio, a privately owned software company that provides a platform for drug companies and life science researchers to search, discover, and share knowledge across public and proprietary data.